杭州默银医药技术

Hangzhou Moyin Pharmaceutical Technology is a Chinese biotechnology company headquartered in Hangzhou, specializing in the research and development of innovative small molecule drugs. Established in 2021, the company focuses on therapeutic areas with high unmet needs, particularly oncology and metabolic diseases. Moyin Pharmaceutical Technology operates out of the Hangzhou Pharmaceutical Port, leveraging the region's robust life sciences infrastructure to support its drug discovery programs. The firm is currently in the early stages of its development cycle, focusing on preclinical research and platform optimization. Its business model centers on internal innovation and the advancement of a proprietary pipeline of therapeutic candidates.